Stock comparison
BrightSpring Health Services, Inc. Tangible Equity Unit
Halozyme Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BTSGU
BrightSpring Health Services, Inc. Tangible Equity Unit
Market cap
$37.63B
Sector
Healthcare
HALO
Halozyme Therapeutics
Market cap
$8.1B
Sector
Healthcare
Overall winner
Halozyme Therapeutics HALO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BTSGU | HALO | Winner |
|---|---|---|---|
| Warren Buffett | 49D | 79B | HALO |
| Benjamin Graham | 65D | 83A | HALO |
| Philip Fisher | 58C | 65B | HALO |
| Peter Lynch | 58C | 53D | BTSGU |
| Joel Greenblatt | 40D | 40D | Tie |
| Charlie Munger | 43D | 80C | HALO |
| Terry Smith | 45D | 84A | HALO |
Side-by-side metrics
| Metric | BTSGU | HALO |
|---|---|---|
| Market cap | $37.63B | $8.1B |
| P/E (TTM) | 37.3x | 24.0x |
| EV/EBIT | 24.9x | 10.2x |
| ROIC (TTM) | 7.84% | 23.65% |
| Gross margin | 12.18% | 81.24% |
| Net margin | 2.27% | 23.13% |
| Revenue CAGR 5y | 17.83% | 33.23% |
| EPS CAGR 5y | 34.18% | -1.98% |
| Debt / Equity | 1.4x | 1.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BTSGU leads on
- EPS CAGR 5y34.18%vs -1.98%+106%
- Market cap$37.63Bvs $8.1B+78%
HALO leads on
- Net margin23.13%vs 2.27%+90%
- Gross margin81.24%vs 12.18%+85%
- ROIC (TTM)23.65%vs 7.84%+67%
- EV/EBIT10.2xvs 24.9x+59%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.